Trial intelligence / Profile preview

RIGHT-2 trial of transdermal glyceryl trinitrate in suspected acute stroke

ISRCTN26986053Phase 3Completed

Sponsor
University of Nottingham
Start
May 2015
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial of nitroglycerin in stroke (2 arms), sponsored by University of Nottingham. Primary endpoint: Modified Rankin Scale at 90 days. Started May 2015; status: completed.

02

Drugs

nitroglycerin
03

Conditions

stroke

Beyond the preview

Go deeper on ISRCTN26986053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN26986053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call